| 1 |
Xia JG, Li B, Zhang H, Li QX, Lam SM, Yin CL, Tian H, Shui G. Precise Metabolomics Defines Systemic Metabolic Dysregulation Distinct to Acute Myocardial Infarction Associated With Diabetes. Arterioscler Thromb Vasc Biol 2023;43:581-96. [PMID: 36727520 DOI: 10.1161/ATVBAHA.122.318871] [Reference Citation Analysis]
|
| 2 |
Ji X, Meng Y, Wang Q, Tong T, Liu Z, Lin J, Li B, Wei Y, You X, Lei Y, Song M, Wang L, Guo Y, Qiu Y, Chen Z, Mai B, Xie S, Wu J, Cao N. Cysteine-Based Redox-Responsive Nanoparticles for Fibroblast-Targeted Drug Delivery in the Treatment of Myocardial Infarction. ACS Nano 2023. [PMID: 36929948 DOI: 10.1021/acsnano.2c10042] [Reference Citation Analysis]
|
| 3 |
Kitsuka T, Takahashi F, Reinhardt J, Watanabe T, Ulziibayar A, Yimit A, Kelly J, Shinoka T. Advances in Cardiac Tissue Engineering. Bioengineering 2022;9:696. [DOI: 10.3390/bioengineering9110696] [Reference Citation Analysis]
|
| 4 |
Hoang DM, Pham PT, Bach TQ, Ngo ATL, Nguyen QT, Phan TTK, Nguyen GH, Le PTT, Hoang VT, Forsyth NR, Heke M, Nguyen LT. Stem cell-based therapy for human diseases. Signal Transduct Target Ther 2022;7:272. [PMID: 35933430 DOI: 10.1038/s41392-022-01134-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 5 |
Roacho-pérez JA, Garza-treviño EN, Moncada-saucedo NK, Carriquiry-chequer PA, Valencia-gómez LE, Matthews ER, Gómez-flores V, Simental-mendía M, Delgado-gonzalez P, Delgado-gallegos JL, Padilla-rivas GR, Islas JF. Artificial Scaffolds in Cardiac Tissue Engineering. Life 2022;12:1117. [DOI: 10.3390/life12081117] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 6 |
Huang H, Huang W. Regulation of Endothelial Progenitor Cell Functions in Ischemic Heart Disease: New Therapeutic Targets for Cardiac Remodeling and Repair. Front Cardiovasc Med 2022;9:896782. [DOI: 10.3389/fcvm.2022.896782] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 7 |
Matta A, Nader V, Lebrin M, Gross F, Prats A, Cussac D, Galinier M, Roncalli J. Pre-Conditioning Methods and Novel Approaches with Mesenchymal Stem Cells Therapy in Cardiovascular Disease. Cells 2022;11:1620. [DOI: 10.3390/cells11101620] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 8 |
Dergilev КV, Tsokolaeva ZI, Beloglazova IB, Vasilets YD, Traktuev DO, Kulbitsky NB, Parfenova EV. Role of Urokinase-Type Plasminogen Activator Receptor in the Regulation of Angiogenic Properties of Sca1+ Vasculogenic Progenitor Cells. Obŝaâ reanimatologiâ 2022;18:76-82. [DOI: 10.15360/1813-9779-2022-2-76-82] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 9 |
Zhang Q, Wang L, Wang S, Cheng H, Xu L, Pei G, Wang Y, Fu C, Jiang Y, He C, Wei Q. Signaling pathways and targeted therapy for myocardial infarction. Signal Transduct Target Ther 2022;7:78. [PMID: 35273164 DOI: 10.1038/s41392-022-00925-z] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 40.0] [Reference Citation Analysis]
|
| 10 |
An Z, Tian J, Liu Y, Zhao X, Yang X, Yong J, Liu L, Zhang L, Jiang W, Song X, Zhang H. Exosomes as a Cell-free Therapy for Myocardial Injury Following Acute Myocardial Infarction or Ischemic Reperfusion. Aging and disease 2022;13:1770. [DOI: 10.14336/ad.2022.0416] [Reference Citation Analysis]
|
| 11 |
Yudintceva N, Lomert E, Mikhailova N, Tolkunova E, Agadzhanian N, Samochernych K, Multhoff G, Timin G, Ryzhov V, Deriglazov V, Mazur A, Shevtsov M. Targeting Brain Tumors with Mesenchymal Stem Cells in the Experimental Model of the Orthotopic Glioblastoma in Rats. Biomedicines 2021;9:1592. [PMID: 34829821 DOI: 10.3390/biomedicines9111592] [Reference Citation Analysis]
|
